Community-Acquired Bacterial Pneumonia (CABP)
3 clinical trials · Condition
◉ Watch Community-Acquired Bacterial Pneumonia (CABP)
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Oral Nafithromycin in CABP (NCT02903836) | Wockhardt | 2016-11-18 |
| Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia (NCT01666743) | Forest Laboratories | 2012-11-01 |
| Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia (NCT01198626) | Furiex Pharmaceuticals, Inc | 2010-10-01 |
Track Community-Acquired Bacterial Pneumonia (CABP) automatically
Every clearance here is in the API, with alerts when new ones post.